Home/Filings/4/0001209191-13-018646
4//SEC Filing

Greene Rick Scott 4

Accession 0001209191-13-018646

CIK 0001087294other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:43 PM ET

Size

4.6 KB

Accession

0001209191-13-018646

Insider Transaction Report

Form 4
Period: 2013-03-26
Greene Rick Scott
Chief Financial Officer
Transactions
  • Award

    Common stock

    2013-03-26$4.78/sh+6,000$28,68039,000 total
Footnotes (1)
  • [F1]Restricted stock award will vest 100% on 3/18/2017.

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1
  • filerCIK 0001531483

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:43 PM ET
Size
4.6 KB